169 related articles for article (PubMed ID: 28545128)
21. MLF1 is a proapoptotic antagonist of HOP complex-mediated survival.
Sun Y; Chao JR; Xu W; Pourpak A; Boyd K; Moshiach S; Qi GY; Fu A; Shao HR; Pounds S; Morris SW
Biochim Biophys Acta Mol Cell Res; 2017 Apr; 1864(4):719-727. PubMed ID: 28137643
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.
Agathanggelou A; Dallol A; Zöchbauer-Müller S; Morrissey C; Honorio S; Hesson L; Martinsson T; Fong KM; Kuo MJ; Yuen PW; Maher ER; Minna JD; Latif F
Oncogene; 2003 Mar; 22(10):1580-8. PubMed ID: 12629521
[TBL] [Abstract][Full Text] [Related]
23. A cryptic submicroscopic deletion of 5' MLF1-3' NPM1 segment on derivative chromosome 3 in a patient with acute myeloid leukemia with t(3;5)(q25;q35).
Gao M; Wang G; Wang X; Kim YM; Lu X; Lu J; Gu Y; Pang H; Lee J; Sternenberger A; Li S
Leuk Lymphoma; 2015; 56(9):2735-8. PubMed ID: 25629988
[No Abstract] [Full Text] [Related]
24. Loss of the NPM1 gene in myeloid disorders with chromosome 5 rearrangements.
Berger R; Busson M; Baranger L; Hélias C; Lessard M; Dastugue N; Speleman F
Leukemia; 2006 Feb; 20(2):319-21. PubMed ID: 16341035
[TBL] [Abstract][Full Text] [Related]
25. Modulation of mutant Huntingtin aggregates and toxicity by human myeloid leukemia factors.
Banerjee M; Datta M; Bhattacharyya NP
Int J Biochem Cell Biol; 2017 Jan; 82():1-9. PubMed ID: 27840155
[TBL] [Abstract][Full Text] [Related]
26. Identification of Mitochondrial DNA Variants Associated With Risk of Neuroblastoma.
Chang X; Liu Y; Glessner J; Hou C; Qu H; Nguyen K; Sleiman P; Lee L; Diskin SJ; Maris JM; Hakonarson H
J Natl Cancer Inst; 2022 Jun; 114(6):910-913. PubMed ID: 35134187
[TBL] [Abstract][Full Text] [Related]
27.
Zhang Z; Chang Y; Jia W; Zhang J; Zhang R; Zhu J; Yang T; Xia H; Zou Y; He J
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29339420
[TBL] [Abstract][Full Text] [Related]
28. Genetics and genomics of neuroblastoma.
Capasso M; Diskin SJ
Cancer Treat Res; 2010; 155():65-84. PubMed ID: 20517688
[TBL] [Abstract][Full Text] [Related]
29. cDNA cloning, expression pattern, and chromosomal localization of Mlf1, murine homologue of a gene involved in myelodysplasia and acute myeloid leukemia.
Hitzler JK; Witte DP; Jenkins NA; Copeland NG; Gilbert DJ; Naeve CW; Look AT; Morris SW
Am J Pathol; 1999 Jul; 155(1):53-9. PubMed ID: 10393836
[TBL] [Abstract][Full Text] [Related]
30. cDNA cloning and characterization of a novel gene encoding the MLF1-interacting protein MLF1IP.
Hanissian SH; Akbar U; Teng B; Janjetovic Z; Hoffmann A; Hitzler JK; Iscove N; Hamre K; Du X; Tong Y; Mukatira S; Robertson JH; Morris SW
Oncogene; 2004 Apr; 23(20):3700-7. PubMed ID: 15116101
[TBL] [Abstract][Full Text] [Related]
31. Estimation of copy number aberrations: Comparison of exome sequencing data with SNP microarrays identifies homozygous deletions of 19q13.2 and CIC in neuroblastoma.
Fransson S; Östensson M; Djos A; Javanmardi N; Kogner P; Martinsson T
Int J Oncol; 2016 Mar; 48(3):1103-16. PubMed ID: 26794043
[TBL] [Abstract][Full Text] [Related]
32. Impact of a single nucleotide polymorphism in the MDM2 gene on neuroblastoma development and aggressiveness: results of a pilot study on 239 patients.
Cattelani S; Defferrari R; Marsilio S; Bussolari R; Candini O; Corradini F; Ferrari-Amorotti G; Guerzoni C; Pecorari L; Menin C; Bertorelle R; Altavista P; McDowell HP; Boldrini R; Dominici C; Tonini GP; Raschellà G; Calabretta B
Clin Cancer Res; 2008 Jun; 14(11):3248-53. PubMed ID: 18519749
[TBL] [Abstract][Full Text] [Related]
33. GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3.
Fabian J; Lodrini M; Oehme I; Schier MC; Thole TM; Hielscher T; Kopp-Schneider A; Opitz L; Capper D; von Deimling A; Wiegand I; Milde T; Mahlknecht U; Westermann F; Popanda O; Roels F; Hero B; Berthold F; Fischer M; Kulozik AE; Witt O; Deubzer HE
Cancer Res; 2014 May; 74(9):2604-16. PubMed ID: 24419085
[TBL] [Abstract][Full Text] [Related]
34. Activating mutations in ALK provide a therapeutic target in neuroblastoma.
George RE; Sanda T; Hanna M; Fröhling S; Luther W; Zhang J; Ahn Y; Zhou W; London WB; McGrady P; Xue L; Zozulya S; Gregor VE; Webb TR; Gray NS; Gilliland DG; Diller L; Greulich H; Morris SW; Meyerson M; Look AT
Nature; 2008 Oct; 455(7215):975-8. PubMed ID: 18923525
[TBL] [Abstract][Full Text] [Related]
35. MLF1 protein is a potential therapy target for lung adenocarcinoma.
Li X; Min S; Wang H; Shen Y; Li W; Chen Y; Wang X
Int J Clin Exp Pathol; 2018; 11(7):3533-3541. PubMed ID: 31949731
[TBL] [Abstract][Full Text] [Related]
36. Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data.
Łastowska M; Viprey V; Santibanez-Koref M; Wappler I; Peters H; Cullinane C; Roberts P; Hall AG; Tweddle DA; Pearson AD; Lewis I; Burchill SA; Jackson MS
Oncogene; 2007 Nov; 26(53):7432-44. PubMed ID: 17533364
[TBL] [Abstract][Full Text] [Related]
37. Identification of a novel recurrent 1q42.2-1qter deletion in high risk MYCN single copy 11q deleted neuroblastomas.
Fieuw A; Kumps C; Schramm A; Pattyn F; Menten B; Antonacci F; Sudmant P; Schulte JH; Van Roy N; Vergult S; Buckley PG; De Paepe A; Noguera R; Versteeg R; Stallings R; Eggert A; Vandesompele J; De Preter K; Speleman F
Int J Cancer; 2012 Jun; 130(11):2599-606. PubMed ID: 21796619
[TBL] [Abstract][Full Text] [Related]
38. Allelic variants of CAMTA1 and FLJ10737 within a commonly deleted region at 1p36 in neuroblastoma.
Henrich KO; Claas A; Praml C; Benner A; Mollenhauer J; Poustka A; Schwab M; Westermann F
Eur J Cancer; 2007 Feb; 43(3):607-16. PubMed ID: 17222547
[TBL] [Abstract][Full Text] [Related]
39. CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus.
Russell MR; Penikis A; Oldridge DA; Alvarez-Dominguez JR; McDaniel L; Diamond M; Padovan O; Raman P; Li Y; Wei JS; Zhang S; Gnanchandran J; Seeger R; Asgharzadeh S; Khan J; Diskin SJ; Maris JM; Cole KA
Cancer Res; 2015 Aug; 75(15):3155-66. PubMed ID: 26100672
[TBL] [Abstract][Full Text] [Related]
40. Silencing of MYCN by RNA interference induces growth inhibition, apoptotic activity and cell differentiation in a neuroblastoma cell line with MYCN amplification.
Nara K; Kusafuka T; Yoneda A; Oue T; Sangkhathat S; Fukuzawa M
Int J Oncol; 2007 May; 30(5):1189-96. PubMed ID: 17390021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
